BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25747742)

  • 1. Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy.
    Huijskens MJ; Walczak M; Sarkar S; Atrafi F; Senden-Gijsbers BL; Tilanus MG; Bos GM; Wieten L; Germeraad WT
    Cytotherapy; 2015 May; 17(5):613-20. PubMed ID: 25747742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
    Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
    PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
    Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
    Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells differentiated in vitro from cord blood CD34
    Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
    Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and expansion of natural killer cells for NK cell-based immunotherapy.
    Becker PS; Suck G; Nowakowska P; Ullrich E; Seifried E; Bader P; Tonn T; Seidl C
    Cancer Immunol Immunother; 2016 Apr; 65(4):477-84. PubMed ID: 26810567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK cells with Enhanced Antitumor Activity.
    Oberoi P; Kamenjarin K; Ossa JFV; Uherek B; Bönig H; Wels WS
    Cells; 2020 Mar; 9(4):. PubMed ID: 32230942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34(+) Hematopoietic Stem and Progenitor Cells.
    Roeven MW; Thordardottir S; Kohela A; Maas F; Preijers F; Jansen JH; Blijlevens NM; Cany J; Schaap N; Dolstra H
    Stem Cells Dev; 2015 Dec; 24(24):2886-98. PubMed ID: 26414401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
    Zhu H; Kaufman DS
    Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion.
    Frias AM; Porada CD; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
    Exp Hematol; 2008 Jan; 36(1):61-8. PubMed ID: 18155552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
    Masuyama J; Murakami T; Iwamoto S; Fujita S
    Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
    Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.
    Luevano M; Madrigal A; Saudemont A
    Cell Mol Immunol; 2012 Jul; 9(4):310-20. PubMed ID: 22705914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
    Tam YK; Martinson JA; Doligosa K; Klingemann HG
    Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ex vivo expansion of highly purified NK cells from human peripheral blood].
    Li XH; Ma J; Wang FF; Dou LP; Li M; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):373-7. PubMed ID: 17493350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.